Lymphoma (mantle cell) - bendamustine (1st line, with rituximab): equality impact assessment
Lymphoma (mantle cell) - bendamustine (1st line, with rituximab): response to consultee and commentator comments on the draft scope
Lymphoma (mantle cell) - bendamustine (1st line, with rituximab): final matrix
Lymphoma (mantle cell) - bendamustine (1st line, with rituximab): final scope
Lymphoma (mantle cell) - bendamustine (1st line, with rituximab): draft scope consultation (post referral) - October 2012
Lymphoma (mantle cell) - bendamustine (1st line, with rituximab): provisional matrix (post referral) - October 2012